SBIR Phase I: Advanced Tracking Device for Patients with Cognitive Impairments
Award amount
$99,000Program and phase
SBIR · Phase IAward year
2008Award details
- Awarding agency
- National Science Foundation
- Branch
- Not reported
- Recipient company
- FABRICO TECHNOLOGY, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- YMAJVR21PC43
- Solicitation number
- NSF 00-144
- Topic code
- BT
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Development of antibody treatment of MDR ESKAPE Pathogen, P. Aeruginosa.
- Development of antibody treatment of MDR ESKAPE Pathogen, P. aeruginosa
- Development of Small Molecule Therapeutics Specifically Targeting Members of the Bunyavirales Order
- Non-canonical genetic code implementation with an optimized, easily scaled cell free lysate system
- Development of novel Small Molecule Antiviral Endocytosis Inhibition pathway
Research funding history
14 SBIR/STTR records share this UEI (2008–2025). Reported award amounts total $5,542,186. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Defense, National Science Foundation